REZI vs DOCS
Comparison between Resideo Technologies Inc (REZI, Company) and Doximity Inc - Class A (DOCS, Company).
REZI is from the Industrials sector, while DOCS is from the Healthcare sector.
5-Year PerformanceREZI has outperformed DOCS, delivering a return of +3.3% compared to -20.7%
REZI vs DOCS - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
REZI vs DOCS - Historical Returns
Returns include dividend reinvestment.
REZI vs DOCS - Annual Returns (2018 - 2026)
Returns include dividend reinvestment.
| Year | REZI | DOCS |
|---|---|---|
| 2026 | +5.04% | -42.27% |
| 2025 | +54.17% | -17.33% |
| 2024 | +25.68% | +86.94% |
| 2023 | +12.16% | -14.64% |
| 2022 | -37.48% | -34.91% |
| 2021 | +22.26% | -5.42% |
| 2020 | +74.69% | N/A |
| 2019 | -42.20% | N/A |
| 2018 | -29.14% | N/A |
REZI vs DOCS Drawdown Comparison
The maximum drawdown for REZI was -87.29%, occurring on Apr 3, 2020. Recovery took 603 trading sessions.
The maximum drawdown for DOCS was -82.35%, occurring on May 14, 2026. This drawdown has not yet recovered.
The current REZI drawdown is -17.01%. The current DOCS drawdown is -75.50%.
| Rank | REZI | DOCS |
|---|---|---|
| #1 | -87.29% Oct 16, 2018 - Mar 11, 2021 | -82.35% Sep 10, 2021 - May 14, 2026 |
| #2 | -56.13% Jun 8, 2021 - Aug 13, 2025 | -21.26% Jul 26, 2021 - Aug 11, 2021 |
| #3 | -39.80% Oct 24, 2025 - May 19, 2026 | -19.76% Jun 28, 2021 - Jul 22, 2021 |
| #4 | -15.33% Mar 11, 2021 - Jun 4, 2021 | -12.81% Aug 25, 2021 - Sep 2, 2021 |
| #5 | -7.04% Sep 30, 2025 - Oct 23, 2025 | -7.11% Aug 16, 2021 - Aug 23, 2021 |
| #6 | -4.42% Aug 13, 2025 - Aug 22, 2025 | -5.46% Sep 3, 2021 - Sep 9, 2021 |
| #7 | -3.82% Sep 22, 2025 - Sep 30, 2025 | -4.44% Aug 12, 2021 - Aug 16, 2021 |
| #8 | -3.17% Aug 27, 2025 - Sep 4, 2025 | N/A |
| #9 | -1.90% Sep 8, 2025 - Sep 11, 2025 | N/A |
Correlation
Correlation between REZI and DOCS is 0.25 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks